Human epidermal growth factor receptor 2 (HER2) gene is amplified in approximately 15% of invasive breast cancer (BC) leading to HER2 protein overexpression.1, 2, 3, 4. This evidence concerns the gene ERBB2 and invasive breast carcinoma.